Answers are grounded in this paper and cite their sources.
This evaluation reveals glycemic control associations in prediabetes and type 2 diabetes, suggesting insulin resistance indices could enhance patient care.
Introduction: This study was designed for comparing the performance of insulin resistance (IR) indices in individuals with prediabetes and type 2 diabetes mellitus (T2DM). Methods: Participants were classified into four categories according to HbA1c using the American Diabetes Association criteria: control group (<5.7%) (n=192), prediabetes (5.7%-6.4%) (n=147), regulated T2DM (6.5%-7.0%) (n=28), and non-regulated T2DM (>7.0%) (n=61). Patient records and laboratory information system data were reviewed to determine serum glucose, triglyceride, high-density lipoprotein cholesterol (HDL-C), insulin, and to determine homeostatic model assessment of IR (HOMA-IR), insulin sensitivity index (ISI/McAuley index), quantitative insulin sensitivity check index (QUICKI), triglyceride to HDL-C ratio (TG/HDL-C), and triglyceride-glucose (TyG) index. Results: The non-regulated T2DM group had higher HOMA-IR and TyG levels and lower QUICKI values than the prediabetic and regulated T2DM groups. TyG and HOMA-IR indices have a positive correlation with HbA1c (r=0.547 and r=0.456, respectively). According to the receiver operating characteristic analysis, TyG had the highest area under the curve (AUC) of 0.749 (0.705-0.789) to identify patients with HbA1c ≥5.70%, and the Turkish population-specific cut-off value was set at 8.55. Findings from the binary logistic regression highlighted that TyG, HOMA-IR, TG/HDL-C, QUICKI, and ISI indices were associated with patients with HbA1c ≥5.70%, independent of age and sex. Conclusion: Among the evaluated IR indices, the TyG index demonstrated the highest correlation coefficient with HbA1c. In addition, it yielded the largest AUC, indicating superior diagnostic performance compared to the other indices. These findings suggest that the TyG index may serve as a useful marker of IR in individuals with prediabetes and T2DM.
No takes yet. Share an insight, caveat, or question.
Aydin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: